NCPDP Foundation Honors Xact Laboratories with Charles Pulido Excellence Award 2026
On May 4, 2026, Xact Laboratories was honored with the prestigious Charles Pulido, R.Ph. Excellence Award by the NCPDP Foundation during its Annual Technology Business Conference held in Scottsdale, Arizona. This recognition comes as a part of the Leadership Appreciation Dinner, which celebrates outstanding contributions to the healthcare industry.
Xact Laboratories received this accolade for its impressive completion of research that integrates pharmacogenomic (PGx) data effectively into pharmacist workflows. According to the study, nearly 95% of patients exhibited medication issues when assessed with PGx data. Moreover, 59% of the prescribers consulted agreed to limit access to certain medications based on the findings from PGx results. Notably, the strong patient engagement aspect was highlighted, with 87% of consultations being completed successfully. This showcases the growing significance of precision medicine in pharmacy practice.
As emphasized by J.W. Hill, the Executive Director of the NCPDP Foundation, this award acknowledges Xact Laboratories' unwavering commitment to collaboration, innovation, and making a meaningful impact within healthcare. The research showcases how utilizing pharmacogenomic data can lead to identifying clinically relevant medication challenges, promote safer prescribing practices, and enhance patient involvement in their treatment plans, thereby propelling forward the field of precision medicine.
Rob Todd, the CEO and Co-founder of Xact Laboratories, expressed heartfelt gratitude for receiving this award. He highlighted that the honor reflects the ability of various segments within the pharmacy and healthcare sphere to unite towards a common goal of genetic medication optimization in everyday hospital practices. Todd believes that the integration of personalized genomic data into pharmacy operations is a vital step toward enabling informed and safer medication prescriptions tailored to individual patient needs.
The Charles Pulido, R.Ph. Excellence Award is bestowed annually to one grantee, recognizing their embodiment of Mr. Pulido's values: collaboration, innovation, and excellence in healthcare through impactful research funded by the NCPDP Foundation.
Xact Laboratories’ groundbreaking efforts showcase a pivotal moment in the pharmacy field, illustrating the potential of genetic insights to advance patient care. Their study not only underlines the importance of PGx data in enhancing medication safety and effectiveness but also demonstrates a model for integrating advanced medical practices into daily operations efficiently.
The NCPDP Foundation continues to lead initiatives that advocate for improved data exchange across the healthcare landscape, aiming to eliminate barriers that adversely affect patient care quality. Being a 501(c)(3) nonprofit organization based in Scottsdale, Arizona, they collaborate with various stakeholders to spearhead transformative research that reinforces pharmacy interoperability and elevates the standard of care.
As healthcare advances toward a more personalized approach, the contributions from organizations like Xact Laboratories and support from the NCPDP Foundation will be crucial in realizing the aspirations of the next generation of healthcare practices.
Xact Laboratories received this accolade for its impressive completion of research that integrates pharmacogenomic (PGx) data effectively into pharmacist workflows. According to the study, nearly 95% of patients exhibited medication issues when assessed with PGx data. Moreover, 59% of the prescribers consulted agreed to limit access to certain medications based on the findings from PGx results. Notably, the strong patient engagement aspect was highlighted, with 87% of consultations being completed successfully. This showcases the growing significance of precision medicine in pharmacy practice.
As emphasized by J.W. Hill, the Executive Director of the NCPDP Foundation, this award acknowledges Xact Laboratories' unwavering commitment to collaboration, innovation, and making a meaningful impact within healthcare. The research showcases how utilizing pharmacogenomic data can lead to identifying clinically relevant medication challenges, promote safer prescribing practices, and enhance patient involvement in their treatment plans, thereby propelling forward the field of precision medicine.
Rob Todd, the CEO and Co-founder of Xact Laboratories, expressed heartfelt gratitude for receiving this award. He highlighted that the honor reflects the ability of various segments within the pharmacy and healthcare sphere to unite towards a common goal of genetic medication optimization in everyday hospital practices. Todd believes that the integration of personalized genomic data into pharmacy operations is a vital step toward enabling informed and safer medication prescriptions tailored to individual patient needs.
The Charles Pulido, R.Ph. Excellence Award is bestowed annually to one grantee, recognizing their embodiment of Mr. Pulido's values: collaboration, innovation, and excellence in healthcare through impactful research funded by the NCPDP Foundation.
Xact Laboratories’ groundbreaking efforts showcase a pivotal moment in the pharmacy field, illustrating the potential of genetic insights to advance patient care. Their study not only underlines the importance of PGx data in enhancing medication safety and effectiveness but also demonstrates a model for integrating advanced medical practices into daily operations efficiently.
The NCPDP Foundation continues to lead initiatives that advocate for improved data exchange across the healthcare landscape, aiming to eliminate barriers that adversely affect patient care quality. Being a 501(c)(3) nonprofit organization based in Scottsdale, Arizona, they collaborate with various stakeholders to spearhead transformative research that reinforces pharmacy interoperability and elevates the standard of care.
As healthcare advances toward a more personalized approach, the contributions from organizations like Xact Laboratories and support from the NCPDP Foundation will be crucial in realizing the aspirations of the next generation of healthcare practices.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.